Back

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

28 August 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Late-Breaking Science Posters PCI Angina pectoris stable ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Gb John Mancini

University of British Columbia, Vancouver (Canada)

4 More presentations in this session

Presentation thumbnail
The Platelet Aggregation with tiCagrelor Inhibition and FentanYl Randomized Trial
Professor J. Mcevoy (Galway, IE)
Slides
Presentation thumbnail
Stroke after coronary revascularization: an individual patient data pooled analysis of 11 randomised trials comparing percutaneous coronary intervention with coronary artery bypass grafting
Doctor S. Head (Rotterdam, NL)
Slides
Presentation thumbnail
The EROSION study (Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion): A 1-Year Follow Up Study
Professor I. Jang (Boston, US)
Slides
Presentation thumbnail
A comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: final results of the Elderly-ACS
Professor S. De Servi (Pavia, IT)
Slides

Access the full session

Session thumbnail
Late-Breaking Science Posters PCI

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Determinants of revascularization and outcomes in patients with suspected/known CAD
20 May 2024
thumbnail
Congress Presentation
The impact of statin treatment intensity after endovascular revascularization for lower extremity peripheral artery disease
27 August 2022
thumbnail
Webinar
The year in cardiology 2018
12 December 2018
thumbnail
Congress Presentation
Clinical outcomes of complete revascularization in acute myocardial infarction patients with high bleeding risk and multivessel disease
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources